Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors

Research Question:
Is the drug BMS-813160 safe, tolerable and effective when given alone or in combination with other chemotherapy drugs in patients with metastatic colorectal and pancreatic cancers?

Basic Study Information

Purpose:
This study will evaluate the safety profile, tolerability, and effectiveness of the drug BMS-813160 in patients with metastatic colorectal and pancreatic cancers.

Location: University of Rochester Medical Center
Study Reference #: IGIM18001

Lead Researcher (Principal Investigator)

Lead Researcher:  Marcus Noel

Study Contact Information

Study Coordinator: Nicholas Gerbino
Phone: (585) 273-2605
Email: Nicholas_Gerbino@URMC.Rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search